Kevin Czerney - Mar 3, 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
VP, Chief Accounting Officer
Signature
s/ Dane Baumgardner, Attorney-In-Fact for Kevin Czerney
Stock symbol
XRAY
Transactions as of
Mar 3, 2025
Transactions value $
-$8,390
Form type
4
Date filed
3/5/2025, 06:27 PM
Previous filing
Jan 14, 2025
Next filing
Mar 28, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +8.26K +45.25% $0.00 26.5K Mar 3, 2025 Direct F1
transaction XRAY Common Stock Tax liability -$2.59K -162 -0.61% $15.99 26.3K Mar 3, 2025 Direct F2
transaction XRAY Common Stock Award $0 +462 +1.75% $0.00 26.8K Mar 3, 2025 Direct F3
transaction XRAY Common Stock Tax liability -$5.8K -372 -1.39% $15.59 26.4K Mar 4, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending 3/3/2028.
F2 Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.
F3 On November 16, 2022, the Reporting Person was granted performance-based restricted stock units ("PRSUs"). Each PRSU represents a contingent right to receive a share of the Issuer's Common Stock upon settlement. The Compensation Committee of the Issuer's Board of Directors certifies attainment based on the Issuer's satisfaction of certain performance criteria. The performance criteria were met and 462 PRSUs were certified as attained on March 3, 2025. The PRSUs vest and become shares of the Issuer's Common Stock on May 15, 2025.